# Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque

Study · id `cardio:ct-nct02316886` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02316886](<https://clinicaltrials.gov/study/NCT02316886>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02316886

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1608 participants.

## Technical summary

Registry record NCT02316886. Randomized; no masking; primary purpose treatment. Start 2015-10-05 (actual); primary completion 2023-10-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1608 participants (enrolled count; ClinicalTrials.gov record NCT02316886, source copy `cardio:ctgov-nct02316886-2023-11-18`, retrieved 2026-10-26)
- Started: 2015-10-05 (actual) (ClinicalTrials.gov record NCT02316886, source copy `cardio:ctgov-nct02316886-2023-11-18`, retrieved 2026-10-26)
- Primary completion: 2023-10-19 (actual) (ClinicalTrials.gov record NCT02316886, source copy `cardio:ctgov-nct02316886-2023-11-18`, retrieved 2026-10-26)
- Completion: 2023-10-19 (actual) (ClinicalTrials.gov record NCT02316886, source copy `cardio:ctgov-nct02316886-2023-11-18`, retrieved 2026-10-26)
- Countries: United States; Japan; New Zealand; South Korea; Taiwan (ClinicalTrials.gov record NCT02316886, source copy `cardio:ctgov-nct02316886-2023-11-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02316886-2023-11-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque
- Acronym: PREVENT
- Condition: Coronary Artery Disease
- Condition: Plaque, Atherosclerotic
- Intervention (Device): Coronary intervention
- Intervention (Drug): Optimal Medical treatment
- Lead sponsor: Seung-Jung Park
- Lead sponsor class: OTHER
- Collaborator: CardioVascular Research Foundation, Korea
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Seung-Jung Park (`cardio:org-seung-jung-park`)
- Registry lists this organization as a collaborator: CardioVascular Research Foundation, Korea (`cardio:org-cardiovascular-research-foundation-korea`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial (`cardio:pubmed-38604213`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 50ee2d81691f12973e2105c1630219db0c8b9eb47b38174d9170160b5f679298
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
